Clinical Trial

NKG2D CAR-T(KD-025) in the Treatment of Advanced NKG2DL+ Solid Tumors

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 19, 2024 (before its estimated July 26, 2024 completion). Its status may not reflect the trial's current state.
Summary
This is a Phase 1, single-arm, single-center, open-label study to evaluate the safety and effectiveness of NKG2D-based CAR-T cells infusion in the treatment of advanced NKG2DL+ solid tumors.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06509490
Lead Sponsor Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Conditions Safety Issues
Enrollment 9 participants
Start Date 2024-07-17
Primary Completion 2024-07-26 (estimated)
Study Completion 2026-03-26 (estimated)
Updated on ClinicalTrials.gov 2024-07-19